Company / Working Capital
RIGEL PHARMACEUTICALS INC Working Capital History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$140.9M
FY2025
5-year range
$46.0M / $140.9M
FY2021-FY2025
Trend
+96.3%
vs FY2024
Sector context
#184 of 213
Health Care
What the data says
RIGEL PHARMACEUTICALS INC's working capital of $141M is lower than 86% of companies in the Health Care sector (FY2025). Working Capital has fluctuated over the past 10 years, ranging from $46M in FY2023 to $141M in FY2025.
Based on SEC 10-K filings.
$141M in FY2025 with a 5-year CAGR of +24.0%.
Improved from $46M to $141M over the past 2 years.
Health Care sector context is included.
Working Capital over time
Growth rates
- 3-Year CAGR
- +40.6%
- 5-Year CAGR
- +24.0%
- 10-Year CAGR
- -
Sector benchmark
Bottom 14% in Health CareTop 86% of 213This company $140.9M Sector average $934.6M
▼
-84.9% below sector average
Key checks
Key Insights
- 5-year CAGR of +24.0%, indicating consistent growth.
- In FY2025, working capital increased 96.3% year-over-year.
- Ranks #184 out of 213 companies in the Health Care sector.
- Lowest working capital in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 1.19 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $140.9M | +96.3% |
| FY2024 | $71.8M | +56.1% |
| FY2023 | $46.0M | -9.3% |
| FY2022 | $50.7M | -44.2% |
| FY2021 | $90.9M | +88.8% |
| FY2020 | $48.1M | -20.8% |
| FY2019 | $60.8M | -44.4% |
| FY2018 | $109.3M | +10.2% |
| FY2017 | $99.1M | +84.8% |
| FY2016 | $53.6M | -43.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026